This evidence seems to support the possible use of exogenous Gal-9 to limit the T-cell activity and improve asthma control, since Gal-9 can effectively reduce IgE-mediated mast cells degranulation, eosinophils chemotaxis and activation and allergic response. This evidence concerns the gene LGALS9 and asthma.